Close

Eli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE Inhibitor

August 22, 2016 6:09 AM EDT Send to a Friend
Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) announced they have received U.S. Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login